围术期对乙酰氨基酚使用的环境与经济影响:多中心国际生命周期评估
该研究通过生命周期评估和回顾性审计美国、英国、澳大利亚26家医院的围术期对乙酰氨基酚处方实践,发现静脉制剂碳足迹是口服片剂的12倍,若将口服片剂替代静脉对乙酰氨基酚,2019年三国择期手术可避免约5.7 kt CO2e并节省98.3%的费用。
要点
- 静脉对乙酰氨基酚生命周期碳排放是口服片剂的12倍
- 玻璃瓶比塑料瓶温室气体排放更高
- 口服制剂可行时应优先选择口服对乙酰氨基酚
核心结论
- 静脉对乙酰氨基酚生命周期碳排放是口服片剂的12倍。
- 玻璃瓶温室气体排放高于塑料瓶。
- 口服制剂不可行时才应使用静脉给药。
研究设计与样本
- 对静脉和口服对乙酰氨基酚制剂进行生命周期评估,以二氧化碳当量(CO2e)表示温室气体排放。
- 回顾性审计美国、英国、澳大利亚26家医院的围术期对乙酰氨基酚处方实践和费用。
- 对口服制剂有指征的手术患者,比较实际处方实践与最优口服处方的CO2e和费用。
主要发现
- 1 g剂量碳足迹:口服片剂38 g CO2e,口服液151 g CO2e,静脉制剂310-628 g CO2e(取决于包装和给药耗材类型)。
- 美国符合条件患者中37%接受对乙酰氨基酚(67%为静脉)。
- 英国符合条件患者中85%接受对乙酰氨基酚(80%为静脉)。
- 澳大利亚符合条件患者中66%接受对乙酰氨基酚(70%为静脉)。
- 若将口服片剂替代静脉对乙酰氨基酚的减排机会外推至2019年美英澳择期手术,可避免约5.7 kt CO2e并节省98.3%的费用。
临床怎么用
- 围术期对乙酰氨基酚应优先选择口服片剂,仅在口服制剂不可行时使用静脉给药。
- 选择包装时考虑塑料瓶替代玻璃瓶以减少温室气体排放。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pharmaceuticals account for 19-32% of healthcare greenhouse gas (GHG) emissions. Paracetamol is a common perioperative analgesic agent. We estimated GHG emissions associated with i.v. and oral formulations of paracetamol used in the perioperative period. METHODS: Life-cycle assessment of GHG emissions (expressed as carbon dioxide equivalents CO2e) of i.v. and oral paracetamol preparations was performed. Perioperative paracetamol prescribing practices and costs for 26 hospitals in USA, UK, and Australia were retrospectively audited. For those surgical patients for whom oral formulations were indicated, CO2e and costs of actual prescribing practices for i.v. or oral doses were compared with optimal oral prescribing. RESULTS: The carbon footprint for a 1 g dose was 38 g CO2e (oral tablet), 151 g CO2e (oral liquid), and 310-628 g CO2e (i.v. dependent on type of packaging and administration supplies). Of the eligible USA patients, 37% received paracetamol (67% was i.v.). Of the eligible UK patients, 85% received paracetamol (80% was i.v.). Of the eligible Australian patients, 66% received paracetamol (70% was i.v.). If the emissions mitigation opportunity from substituting oral tablets for i.v. paracetamol is extrapolated to USA, UK, and Australia elective surgical encounters in 2019, ∼5.7 kt CO2e could have been avoided and would save 98.3% of financial costs. CONCLUSIONS: Intravenous paracetamol has 12-fold greater life-cycle carbon emissions than the oral tablet form. Glass vials have higher greenhouse gas emissions than plastic vials. Intravenous administration should be reserved for cases in which oral formulations are not feasible.
引用
- Davies JF, McAlister S, Eckelman MJ, et al. Environmental and financial impacts of perioperative paracetamol use: a multicentre international life-cycle assessment. Br J Anaesth. 2024. PMID: 38296752. doi:10.1016/j.bja.2023.11.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。